Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nxu | NXU | Oct 10, 2024 | 0.24 | -4.47 |
NYLI CBRE Global Infrastructure Megatrends Term Fund | MEGI | Oct 10, 2024 | 14.10 | -1.81 |
NYSE Arca Biotech Index First Trust | FBT | Oct 10, 2024 | 169.89 | -0.02 |
Nyse Composite | NYA | Oct 10, 2024 | 19 496.00 | -0.26 |
Nyxoah SA | NYXH | Oct 10, 2024 | 9.56 | +0.53 |
O-I Glass | OI | Oct 10, 2024 | 13.14 | +1.23 |
Oak Valley Bancorp | OVLY | Oct 10, 2024 | 25.32 | -1.17 |
Oak Woods Acquisition | OAKU | Oct 10, 2024 | 11.15 | 0.00 |
Oaktree Capital A Pref | OAK-A | Oct 10, 2024 | 23.99 | -1.89 |
Oaktree Capital Group B Pref | OAK-B | Oct 10, 2024 | 23.05 | -2.86 |
Oaktree Specialty | OCSL | Oct 10, 2024 | 16.30 | -0.61 |
Oatly ADR | OTLY | Oct 10, 2024 | 0.77 | -5.12 |
Oblong | OBLG | Oct 10, 2024 | 3.70 | -1.86 |
Occidental Petroleum | OXY | Oct 10, 2024 | 54.57 | +1.24 |
Ocean Biomedical | OCEA | Oct 10, 2024 | 0.91 | -2.49 |
Ocean Power Technologies | OPTT | Oct 10, 2024 | 0.15 | +1.54 |
Oceaneering International | OII | Oct 10, 2024 | 25.80 | +0.62 |
OceanFirst Financial | OCFC | Oct 10, 2024 | 17.56 | -0.40 |
OceanFirst Pref | OCFCP | Oct 10, 2024 | 25.26 | 0.00 |
OceanPal | OP | Oct 10, 2024 | 1.64 | -1.12 |
Ocugen | OCGN | Oct 10, 2024 | 0.95 | -0.04 |
Ocular Therapeutix | OCUL | Oct 10, 2024 | 9.22 | -0.86 |
Oculis | OCS | Oct 10, 2024 | 15.00 | -1.32 |
Ocuphire Pharma | OCUP | Oct 10, 2024 | 1.23 | -3.15 |
Oddity Tech | ODD | Oct 10, 2024 | 39.20 | -1.86 |
Odyssey Marine Exploration | OMEX | Oct 10, 2024 | 0.61 | -6.91 |
Offerpad Solutions A | OPAD | Oct 10, 2024 | 2.83 | -12.38 |
Office Properties | OPI | Oct 10, 2024 | 1.99 | 0.00 |
OFG Bancorp | OFG | Oct 10, 2024 | 42.75 | +0.97 |
OFS Capital | OFS | Oct 10, 2024 | 8.15 | +0.12 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.